According to the report titled ‘Global Scaffold Technology Market Size study, by Product Type (Hydrogels, Wound Healing. 3D Bioprinting, Immunomodulation), by Disease Type (Cancer, Skin & Integumentary, Dental and Others), by Application (Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Others), by End-Use (Biotechnology and Pharmaceutical Industries, Research Laboratories and Institutes, Hospitals and Diagnostic Centers and Others) and Regional Forecasts 2021-2027’, available with Market Study Report, global scaffold technology market was valued at USD 1.1 billion in 2020 and is expected to register a y-o-y growth rate of 8.4% during 2021-2027, thereby accumulating USD 1.93 billion by the end of the analysis timeframe.
 

Factors like increase in demand for 3D cellular models in biological research for efficient identification of microbial environment, and rise in health expenditure are propelling the growth of global scaffold technology market. As per the report by American Medical Association, the healthcare expenditure in the U.S. surged by 4.6%, from USD 10,680.69 per capita to USD 11,172 in 2017.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3839559/
 

Additionally, technical advancements in the field of healthcare, and usage of 3D bioprinting for tissues & organ reconstruction are further accelerating the market expansion.
 

For the unversed, scaffold technology is a tissue engineering method used for organ and tissue regeneration. The process involves the usage of engineered materials to create desired cell interactions which in turn helps in functional tissue formation.
 

On the contrary, costly manufacturing & research process, coupled with shortage of skilled professionals are the bottlenecks in the industry sphere.
 

By product type, the market is bifurcated into hydrogels, 3D bioprinting, wound healing, and immunomodulation. The segmentation of worldwide scaffold technology market based on disease type includes skin & integumentary, cancer, dental, and others. Speaking of application scope, the industry is classified into drug discovery, stem cell therapy, regenerative medicine, and tissue engineering. Moving on to end user spectrum, the marketplace is classified into research laboratories & institutions, biotechnology & pharmaceutical industries, hospitals & diagnostic centers, and others.
 

From regional frame of reference, the industry landscape is segmented into North America, Latin America, Asia Pacific, and Europe. The report cites that North America holds a major market share currently, owing to infrastructural development in healthcare, and emergence of innovative products.
 

Parallelly, Asia Pacific market is slated to display a strong CAGR during 2021-2027, due to rise in healthcare expenditure, and extensive research carried out by organizations.
 

The prominent players in global scaffold technology market are Xanofi Inc., Matricel GmbH, Merck KGaA, ReproCELL Inc., Medtronic plc, Tecan Trading AG, Becton, Dickinson and Company (BD), Molecular Matrix Inc., 3D Biotek LLC, and Thermo Fisher Scientific Inc.